These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 35911520)
1. Using Synthetic ApoC-II Peptides and nAngptl4 Fragments to Measure Lipoprotein Lipase Activity in Radiometric and Fluorescent Assays. Oldham D; Wang H; Mullen J; Lietzke E; Sprenger K; Reigan P; Eckel RH; Bruce KD Front Cardiovasc Med; 2022; 9():926631. PubMed ID: 35911520 [TBL] [Abstract][Full Text] [Related]
2. Identification of a lipoprotein lipase cofactor-binding site by chemical cross-linking and transfer of apolipoprotein C-II-responsive lipolysis from lipoprotein lipase to hepatic lipase. McIlhargey TL; Yang Y; Wong H; Hill JS J Biol Chem; 2003 Jun; 278(25):23027-35. PubMed ID: 12682050 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach. Reimund M; Wolska A; Risti R; Wilson S; Sviridov D; Remaley AT; Lookene A Biochem Biophys Res Commun; 2019 Oct; 519(1):67-72. PubMed ID: 31477272 [TBL] [Abstract][Full Text] [Related]
4. Human hepatic and lipoprotein lipase: the loop covering the catalytic site mediates lipase substrate specificity. Dugi KA; Dichek HL; Santamarina-Fojo S J Biol Chem; 1995 Oct; 270(43):25396-401. PubMed ID: 7592706 [TBL] [Abstract][Full Text] [Related]
5. Subdomain chimeras of hepatic lipase and lipoprotein lipase. Localization of heparin and cofactor binding. Hill JS; Yang D; Nikazy J; Curtiss LK; Sparrow JT; Wong H J Biol Chem; 1998 Nov; 273(47):30979-84. PubMed ID: 9812994 [TBL] [Abstract][Full Text] [Related]
8. A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides. Wolska A; Lo L; Sviridov DO; Pourmousa M; Pryor M; Ghosh SS; Kakkar R; Davidson M; Wilson S; Pastor RW; Goldberg IJ; Basu D; Drake SK; Cougnoux A; Wu MJ; Neher SB; Freeman LA; Tang J; Amar M; Devalaraja M; Remaley AT Sci Transl Med; 2020 Jan; 12(528):. PubMed ID: 31996466 [TBL] [Abstract][Full Text] [Related]
9. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans. Huff MW; Miller DB; Wolfe BM; Connelly PW; Sawyez CG J Lipid Res; 1997 Jul; 38(7):1318-33. PubMed ID: 9254059 [TBL] [Abstract][Full Text] [Related]
10. Heparin binding triggers human VLDL remodeling by circulating lipoprotein lipase: Relevance to VLDL functionality in health and disease. Jayaraman S; Pérez A; Miñambres I; Sánchez-Quesada JL; Gursky O Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jan; 1867(1):159064. PubMed ID: 34610468 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism. Shirakawa T; Nakajima K; Shimomura Y; Kobayashi J; Stanhope K; Havel P; Machida T; Sumino H; Murakami M Clin Chim Acta; 2015 Feb; 440():193-200. PubMed ID: 25239670 [TBL] [Abstract][Full Text] [Related]
12. Chimeras of hepatic lipase and lipoprotein lipase. Domain localization of enzyme-specific properties. Davis RC; Wong H; Nikazy J; Wang K; Han Q; Schotz MC J Biol Chem; 1992 Oct; 267(30):21499-504. PubMed ID: 1400461 [TBL] [Abstract][Full Text] [Related]
13. Functional characterization of a chimeric lipase genetically engineered from human lipoprotein lipase and human hepatic lipase. Dichek HL; Parrott C; Ronan R; Brunzell JD; Brewer HB; Santamarina-Fojo S J Lipid Res; 1993 Aug; 34(8):1393-40. PubMed ID: 8409770 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of lipoprotein lipase on triolein particles: effect of apolipoprotein C-II. Tajima S; Yokoyama S; Yamamoto A J Biochem; 1984 Dec; 96(6):1753-67. PubMed ID: 6530395 [TBL] [Abstract][Full Text] [Related]
15. Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets. Larsson M; Vorrsjö E; Talmud P; Lookene A; Olivecrona G J Biol Chem; 2013 Nov; 288(47):33997-34008. PubMed ID: 24121499 [TBL] [Abstract][Full Text] [Related]
16. Effects of growth hormone on lipoprotein lipase and hepatic lipase. Oscarsson J; Ottosson M; Edén S J Endocrinol Invest; 1999; 22(5 Suppl):2-9. PubMed ID: 10442563 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the lipolytic activity of endothelial lipase. McCoy MG; Sun GS; Marchadier D; Maugeais C; Glick JM; Rader DJ J Lipid Res; 2002 Jun; 43(6):921-9. PubMed ID: 12032167 [TBL] [Abstract][Full Text] [Related]
18. Modifications of plasma lipoproteins after lipase activation in patients with chylomicronemia. Manzato E; Zambon S; Marin R; Baggio G; Crepaldi G J Lipid Res; 1986 Dec; 27(12):1248-58. PubMed ID: 3559389 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein C-II: the re-emergence of a forgotten factor. Wolska A; Reimund M; Remaley AT Curr Opin Lipidol; 2020 Jun; 31(3):147-153. PubMed ID: 32332429 [TBL] [Abstract][Full Text] [Related]
20. Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II. Kinnunen PK; Jackson RL; Smith LC; Gotto AM; Sparrow JT Proc Natl Acad Sci U S A; 1977 Nov; 74(11):4848-51. PubMed ID: 270715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]